Daniel C Malone
Overview
Explore the profile of Daniel C Malone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
2897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsuura T, Tawfik A, Ben-Umeh K, Hansten P, Malone D
Pharmacotherapy
. 2025 Mar;
45(3):169-176.
PMID: 40035448
Objective: Hyponatremia is a common electrolyte disorder among older adults that can cause serious adverse effects. The purpose of this study was to assess the risk of hyponatremia with the...
2.
Velez F, Rajani R, Malone D, Sun L, Sun L, Bloudek L, et al.
J Med Econ
. 2025 Feb;
28(1):323-334.
PMID: 39964834
Aims: To predict the budget impact of Symvess (Symvess is a trademark of Humacyte Global, Inc.) (acellular tissue engineered vessel-tyod [ATEV]) for extremity arterial trauma repair when autologous vein repair...
3.
Kukhareva P, Facelli J, OBrien M, Gouripeddi R, Kawamoto K, Zhang Y, et al.
medRxiv
. 2024 Nov;
PMID: 39574878
Background: Type 2 diabetes (T2D) represents a major public health burden in the United States, with racial disparities in medication use potentially exacerbating inequities in health outcomes. This study examined...
4.
Malone D, Biskupiak J, Brixner D, Oderda G, Seheult R
Am J Health Syst Pharm
. 2024 Oct;
PMID: 39475087
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are...
5.
Gomez-Lumbreras A, Brendle M, Moorman-Bishir K, Tan M, Malone D
Clin Cardiol
. 2024 Oct;
47(10):e70023.
PMID: 39360666
Introduction: Patients on nonvitamin K antagonist (NVKA) are usually taking other drugs. Potential interaction may increase the gastrointestinal (GI) bleeding risk associated with NVKA. Methods: Observational cohort study using Medicare...
6.
Armstrong E, Franic D, Malone D, Mellors P, Pham S, Masseria C, et al.
Leuk Res
. 2024 Sep;
147:107592.
PMID: 39341087
Background: Disease progression and poor prognosis in higher-risk (HR) myelodysplastic syndrome (MDS) create an urgent need for interventions to improve the patient care experience in this vulnerable population. Patient-centric physician-supported...
7.
Ehsanian R, Malone D, Hambraeus J, Monteiro P, Hodde M, Lee D, et al.
Interv Pain Med
. 2024 Sep;
1(1):100010.
PMID: 39238811
Objective: Apply established principles of evidence-based medicine to the interpretation of the cost-effectiveness analysis related to the MINT Randomized Clinical Trials (RCTs). Design: Editorial. Methods: Spine Intervention Society's guidelines for...
8.
Catania J, Beaver S, Kamath R, Worthington E, Lu M, Gandhi H, et al.
JMIR Ment Health
. 2024 Aug;
11:e57401.
PMID: 39213023
Background: Digital mental health technologies (DMHTs) have the potential to enhance mental health care delivery. However, there is little information on how DMHTs are evaluated and what factors influence their...
9.
Klimchak A, Sedita L, Perfetto E, Gooch K, Malone D
Value Health
. 2024 Aug;
27(12):1641-1647.
PMID: 39094692
Objectives: Quality-adjusted life years (QALYs) have been challenged as a measure of benefit for people with disabilities, particularly for those in low-utility health states or with irreversible disability. This study...
10.
Romero A, Gomez-Lumbreras A, Villa-Zapata L, Tan M, Horn J, Malone D
Am J Health Syst Pharm
. 2024 Jun;
81(22):1142-1157.
PMID: 38894513
Purpose: Due to the low specificity of drug-drug interaction (DDI) warnings, hospitals and healthcare systems would benefit from the ability to customize alerts, thereby reducing the burden of alerts while...